It depends on how you look at it american tax payers fund the developement of these drugs and then the pharma companies charge 1800.00 for a month of it.we all know it doesnt cost that much to get it out to the public.
mikepinkerton
Posts
-
New announcement FDA for June 29 -
New announcement FDA for June 29Yep looks like big pharma gonna get richer because they care about peoples health
-
New announcement FDA for June 29My insurance changed me from tirzep to ozempic to zepbound to wegovy all in 6 months finally gave up went grey
-
Dsip purity testBe good to see whst test shows I have used it and sleep better no side effects did mine nasal.
-
New announcement FDA for June 29Just saw a article saying fda has decided not to allow compounding pharms to do tirzep or ozempic.Looks like craps going to hit the fan.
-
ARA-290 RECONSTITUTION ?Seeing conflicting advice on ARA-290 reconstitution some say acetic solution some say bac water anyone have exp with this
-
EZ Peptides User Review: Very fast shipping and fast response to ?This is a vendor review submitted by mikepinkerton on PeptideCritic.com.
Rating:




(5/5)
Review
Ordered 3 80 mg vials of klow and 2 10 ml bottles of bac recieved my order in 3 days all vials had qr codes that took me to the test for the vials.Test showed purity and mg in vials I used this to average out actual correct doseages for my rat.Great product and service Thanks EZ.
Read the full review: Very fast shipping and fast response to ?Discuss this review, share your own experiences, or ask questions about the vendor.
Please keep discussions respectful and factual.
-
New announcement FDA for June 29I do understand about profitability but many other countries get the good price and we get to pay for it,meanwhile insurance companies play games with coverage.
-
New glp1 4 agonistDoes anyone know anything about the new 4 agonist is called?can not find any info on it.
-
Label MakersI use the niimbot b2 pro didnt want to buy ink and it makes a pretty good label

-
Confused about NEXAPH and NEXAPH SG on telegraphThats kind of what I thought have had really good luck with NEXAPH